PubRank

Susan M Edgerton

Author PubWeight™ 29.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 2009 3.77
2 Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 2009 3.34
3 Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients. J Clin Oncol 2005 2.95
4 Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Horm Cancer 2014 1.55
5 Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells. Int J Cancer 2007 1.50
6 Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol Cancer 2010 1.46
7 Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers. Cell Cycle 2012 1.41
8 Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures. Breast Cancer Res Treat 2012 1.31
9 Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res 2014 1.23
10 The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis. Cancer Res 2008 1.23
11 Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions. Cell Cycle 2011 1.16
12 Perinucleolar compartment prevalence has an independent prognostic value for breast cancer. Cancer Res 2005 1.14
13 Subcellular localization of the HER4 intracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patients. Am J Pathol 2009 1.12
14 Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res 2003 1.03
15 Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells. Breast Cancer Res 2005 1.02
16 Age-associated biomarker profiles of human breast cancer. Int J Biochem Cell Biol 2002 0.98
17 Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling. Breast Cancer Res 2014 0.88
18 Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling. Mol Cancer Res 2009 0.88
19 Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer. Breast Cancer Res 2013 0.86
20 Mammary tumor heterogeneity in wt-ErbB-2 transgenic mice. Comp Med 2004 0.85
21 Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation. Carcinogenesis 2010 0.84